Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S. Winkler, Michael Diamond, Pavlo Gilchuk et al.|Cell|2021Cited by 392
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S. Winkler, Michael Diamond, Pavlo Gilchuk et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 44
Discovery and characterization of a pan-betacoronavirus S2-binding antibodyNicole V. Johnson, Ivelin S. Georgiev, Emanuele Andreano et al.|Structure|2024Cited by 23
Discovery and Characterization of a Pan-betacoronavirus S2-binding antibodyNicole V. Johnson, Ivelin S. Georgiev, Steven C. Wall et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3